New study tests if adding radiation boosts immunotherapy in advanced cancer

This study looked at 42 adults with advanced solid tumors who were already on or about to start immunotherapy (checkpoint inhibitors) and also needed palliative radiotherapy to ease symptoms like pain or breathing trouble. The goal was to see how safe the combination is and whether it might shrink tumors not only where radiation was given but elsewhere in the body (the abscopal effect). Researchers tracked side effects, quality of life, and tumor changes on scans at 1 and 3 months after radiation.